TRENOR CAMERON C. III (Chief Medical Officer) received a stock award from AN2 THERAPEUTICS, INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 9/16/2026ACC: 0001193125-26-393274
Officer· Chief Medical Officer
Since Aug 2026
+350K
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
2
Total transactions
350K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+116.67K
Price / share
—
Trade value
—
% of position
New position
9/15/2026
0.00→116.67K
Total
Net shares
+116.67K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 9/15/2026 | A · Award | +116.67K | — | — | New position | 0.00 | 116.67K |
| Total | +116.67K | $0.00 | ||||||
Derivative Transactions1
Stock Option (right to by)
Direct
Converts to
Common Stock
233.33K shares
Shares
+233.33K
Strike price
5.36
Held after
233.33K
Exercisable
—
9/15/2026
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (right to by) Direct | Common Stock233.33K shares | 9/15/2026 | A · Award | +233.33K | 5.36 | — | 233.33K |